Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 30, 2014Cancer Research

IPH4102, a Humanized KIR3DL2 Antibody with Potent Activity against Cutaneous T-cell Lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAnne Marie‐CardineInsermNVNicolas ViaudInnate Pharma (France)NTNicolas ThonnartInserm

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Marie‐Cardine et al. (2014) studied this question.

synapsesocial.com/papers/6a1bdcc400ee29383e9d0caehttps://doi.org/10.1158/0008-5472.can-14-1456
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The SCID Mouse Mutant: Definition, Characterization, and Potential Uses1991 · 756 citations
  2. 2Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene2002 · 1,894 citations
  3. 3CD158k/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides2012 · 44 citations
  4. 4The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers2008 · 66 citations